Categories AlphaGraphs, Earnings, Health Care
Key highlights from CVS Health (CVS) Q2 2020 earnings results
CVS Health Corporation (NYSE: CVS) reported second quarter 2020 earnings results today.
Total revenues increased 3% to $65.3 billion, driven by growth across all segments.
The COVID-19 pandemic negatively affected results in the Pharmacy Services and Retail/LTC segments as new therapy prescriptions dropped due to lower provider visits.
Net income grew 54.6% to $2.9 billion, or $2.26 per share. Adjusted EPS totaled $2.64.
CVS raised its GAAP EPS guidance range to $5.59-5.72 from $5.47-5.60 and adjusted EPS guidance range to $7.14-7.27 from $7.04-7.17.
Past Performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
What to look for when CVS Health (CVS) reports Q3 earnings
Healthcare company CVS Health Corporation (NYSE: CVS) is all set to report earnings next week, with Wall Street expecting a mixed outcome. The company has been facing challenges in certain
eBay (EBAY): A few factors that helped drive growth in Q3 2024
Shares of eBay Inc. (NASDAQ: EBAY) stayed green on Friday. The stock has gained 32% year-to-date. The ecommerce leader delivered revenue and earnings growth for the third quarter of 2024,
CVX Earnings: Chevron reports lower revenue and profit for Q3 2024
Energy exploration company Chevron Corporation (NYSE: CVX) on Friday announced third-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation dropped to
